Basic research for the clinical application of 18F-THK-5351
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2019
At a glance
- Drugs Fluorine 18 THK 5351 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 07 Jan 2019 Status changed from recruiting to completed.
- 06 Jul 2017 Status changed from not yet recruiting to recruiting.
- 27 Mar 2017 New trial record